This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2019 Nov:121:172-176.

doi: 10.1016/j.ejca.2019.08.030. Epub 2019 Oct 3.

Nivolumab-related mucous membrane pemphigoid

Vincent Sibaud¹, Emmanuelle Vigarios², Aurore Siegfried³, Chloe Bost⁴, Nicolas Meyer⁵, Cecile Pages-Laurent⁶

Affiliations

Affiliations

¹ Oncodermatology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France. Electronic address: sibaud.vincent@iuct-oncopole.fr.
² Oral Medicine Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France.
³ Pathology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France.
⁴ Immunology Department, CHU, Toulouse, France.
⁵ Oncodermatology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France; Dermatology Department, CHU, Toulouse, France.
⁶ Oncodermatology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France.

PMID: 31586756
DOI: 10.1016/j.ejca.2019.08.030

Review

Nivolumab-related mucous membrane pemphigoid

Vincent Sibaud et al. Eur J Cancer. 2019 Nov.

. 2019 Nov:121:172-176.

doi: 10.1016/j.ejca.2019.08.030. Epub 2019 Oct 3.

Authors

Vincent Sibaud¹, Emmanuelle Vigarios², Aurore Siegfried³, Chloe Bost⁴, Nicolas Meyer⁵, Cecile Pages-Laurent⁶

Affiliations

¹ Oncodermatology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France. Electronic address: sibaud.vincent@iuct-oncopole.fr.
² Oral Medicine Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France.
³ Pathology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France.
⁴ Immunology Department, CHU, Toulouse, France.
⁵ Oncodermatology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France; Dermatology Department, CHU, Toulouse, France.
⁶ Oncodermatology Department, Institut Claudius REGAUD and Institut Universitaire du Cancer Toulouse Oncopole, 1 Avenue Irène Joliot-Curie 31059, Toulouse Cedex 9, France.

PMID: 31586756
DOI: 10.1016/j.ejca.2019.08.030

No abstract available

Keywords: Anti–PD-1; Autoimmune blistering disorder; BP180; Gingivitis; Mucous membrane pemphigoid; Nivolumab.

PubMed Disclaimer

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information